Literature DB >> 11264769

Nitric oxide modulates interleukin-1beta and tumour necrosis factor-alpha synthesis, and disease regression by alveolar macrophages in pulmonary tuberculosis.

C H Wang1, H P Kuo.   

Abstract

Pretreatment with nitric oxide synthase (NOS) inhibitors profoundly increases mortality, bacterial burden and pathological tissue damage in mice infected with Mycobacterium tuberculosis. Nitric oxide (NO) production is enhanced in alveolar macrophages (AM) of tuberculosis (TB) patients. Interleukin (IL)-1beta and tumour necrosis factor (TNF)-alpha released from AM are involved in the immune response to mycobacterial infection. The aim of the present study was to examine whether NO is implicated in IL-1beta and TNF-alpha synthesis by AM and related to the resolution of disease activity in TB patients. Purified AM were retrieved by bronchoalveolar lavage from TB patients and normal subjects, and cultured in the presence or absence of a NO inhibitor, NG-monomethyl-L-arginine (L-NMMA). The release of IL-1beta and TNF-alpha, and their mRNA expression were determined by enzyme-linked immunosorbent assay (ELISA) and northern analysis, respectively. The level of nitrite released into the culture medium was determined. The rate of disease regression was evaluated by serial chest radiography. The release of nitrite, IL-1beta and TNF-alpha was much greater from AM of TB patients than normal subjects. NG-monomethyl-L-arginine inhibited the production of nitrite as well as IL-1beta and TNF-alpha in TB patients. The mRNA expression for IL-1beta and TNF-alpha was upregulated in TB patients and was depressed by L-NMMA. Immunocytochemistry using a monoclonal antibody against nuclear factor-kappaB (NF-kappaB) subunit p65 showed NF-kappaB was highly expressed and translocated to the nuclei of AM in TB patients, and was inhibited by L-NMMA. An inhibition of NF-kappaB by pyrrolidine dithiocarbamate attenuated IL-1beta and TNF-alpha synthesis. More generation of NO from cultured AM increased the disease regression in TB patients. We conclude that the enhanced NO generation by AM of TB patients may play an autoregulatory role in amplifying the synthesis of pro-inflammatory cytokines, probably through the activation of NF-kappaB. Nitric oxide may also play an important role in resistance to M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264769     DOI: 10.1046/j.1440-1843.2001.00302.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Sandra D Oland; Eduardo P Amaral; Daniel L Barber; Jacqueline Gonzales; Steven C Derrick; Ruiru Shi; Nathella Pavan Kumar; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Subash Babu; Marta Catalfamo; Andres M Salazar; Laura E Via; Clifton E Barry; Alan Sher
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

2.  Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite.

Authors:  Warren L Lee; Benjamin Gold; Crystal Darby; Nathan Brot; Xiuju Jiang; Luiz Pedro S de Carvalho; Daniel Wellner; Gregory St John; William R Jacobs; Carl Nathan
Journal:  Mol Microbiol       Date:  2009-02       Impact factor: 3.501

Review 3.  Lack of Association Between the IL1B (-511 and +3954), IL1RN VNTR Polymorphisms and Tuberculosis Risk: A Meta-analysis.

Authors:  Qiu-Pin Huang; Ning Liao; Hua Zhao; Min-Li Chen; Zheng-Fu Xie
Journal:  Lung       Date:  2015-09-02       Impact factor: 2.584

4.  Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria.

Authors:  Keiji Hirota; Keishiro Tomoda; Hiroyuki Inagawa; Chie Kohchi; Gen-Ichiro Soma; Kimiko Makino; Hiroshi Terada
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

5.  Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans.

Authors:  Dhammika H M L P Navarathna; Michail S Lionakis; Martin J Lizak; Jeeva Munasinghe; Kenneth W Nickerson; David D Roberts
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

6.  Genetic Polymorphisms of IL1B, IL6, and TNFα in a Chinese Han Population with Pulmonary Tuberculosis.

Authors:  Shouquan Wu; Yu Wang; Miaomiao Zhang; Saurav S Shrestha; Minggui Wang; Jian-Qing He
Journal:  Biomed Res Int       Date:  2018-05-14       Impact factor: 3.411

7.  Polymorphisms of cytokine genes and tuberculosis in two independent studies.

Authors:  Shouquan Wu; Ming-Gui Wang; Yu Wang; Jian-Qing He
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

8.  Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.

Authors:  Ajay Wanchu; Archana Bhatnagar; Madhu Khullar; Archana Sud; Pradeep Bambery; Surjit Singh
Journal:  BMC Infect Dis       Date:  2002-07-29       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.